Associate Editor
Margaretta Colangelo is Co-founder and CEO of Jthereum an enterprise Blockchain company and President of U1 Technologies an enterprise software company. She has published over 300 articles on AI and DeepTech. Margaretta serves on the advisory board of the AI Precision Health Institute at the University of Hawaii Cancer Center. She is based in San Francisco.
Researchers at National University of Singapore have developed a novel protocol using AI and inexpensive equipment to identify live cancer cells in less than 35 minutes with 95% accuracy. The ability to …
Read More
In 2021 companies using AI in Healthcare made significant progress. We have reached the threshold of a new era where advanced technologies will improve the way we understand, treat, and …
Read More
Insilico Medicine announced today that they have started the first human trial of ISM001-055 their AI-designed drug candidate for pulmonary fibrosis. This is a very significant milestone in the history …
Read More
Leucadia Therapeutics has developed AI algorithms that allow neuroscientists to analyze enormous datasets. This new approach incorporates cutting-edge deep learning applied to an advanced method for ultra-resolution contrast-enhanced micro-CT, a …
Read More
This landmark approval of Paige Prostate by the FDA marks the beginning of a new era in the use of AI in pathology and paves the way for new innovations …
Read More
Exciting new research from the AI Precision Health Institute at UH Cancer Center shows that deep learning can distinguish between mammograms of women who will develop breast cancer and those …
Read More